BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 14, 2008
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Fate Therapeutics

Seattle, Wash.

Technology: Small molecules and proteins to redifferentiate cellsin vivo

Disease focus: Musculoskeletal, neurology, cancer

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >